Indication
Tinea Cruris
2 clinical trials
4 products
Product
UHE-103Product
NaftinClinical trial
An Open Label, Parallel Group Comparison Study To Evaluate the Safety Tolerability, and Pharmacokinetics of UHE-103 Cream Versus Naftin Cream in Subjects With Tinea Cruris and/or Tinea Pedis Under Maximal Use ConditionsStatus: Completed, Estimated PCD: 2023-11-14
Clinical trial
Efficacy and Safety of Terbinafine and Itraconazole Monotherapy in Conventional and Increased Doses and in Combination in DermatophytosisStatus: Not yet recruiting, Estimated PCD: 2023-10-01
Product
TerbinafineProduct
Itraconazole